Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts Makes Specialty Pharmacy Portfolio A Priority Through Acquisition

This article was originally published in The Pink Sheet Daily

Executive Summary

Combination of CuraScript and Priority Healthcare will have sales of over $3 bil. Acquisition will provide CuraScript with access to new therapies, including those in fertility, hemophilia, home infusion, pulmonary hypertension and pulmonary fibrosis.

You may also be interested in...



AmerisourceBergen Takes Hit From PBM Specialty Pharmacy Acquisitions

The wholesaler predicts a “revenue shift” because of the loss of customers CuraScript and Priority Healthcare.

AmerisourceBergen Takes Hit From PBM Specialty Pharmacy Acquisitions

The wholesaler predicts a “revenue shift” because of the loss of customers CuraScript and Priority Healthcare.

Accredo Expands Hemophilia Business With Purchase Of Pediatric Services of America

Following Medco's acquisition of Accredo, the specialty pharmacy itself enters into a $72 mil. deal to buy "selected assets" of Pediatric Services of America.

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel